C - Chemistry – Metallurgy – 07 – K
Patent
C - Chemistry, Metallurgy
07
K
C07K 5/10 (2006.01) A61K 9/127 (2006.01) A61K 47/48 (2006.01) C07K 5/06 (2006.01) C07K 5/08 (2006.01) C07K 7/06 (2006.01)
Patent
CA 2276267
Peptide-lipid conjugates are incorporated into liposomes so as to selectively destabilize the liposomes in the vicinity of target peptidase-secreting cells, and hence, to deliver the liposomes to the vicinity of the target cells, or directly into the cells. The liposomes can thus be used to treat mammals for diseases, disorders or conditions, e.g., tumors, microbial infection and inflammations, characterized by the occurrence of peptidase-secreting cells.
On incorpore des conjugués de peptide-lipide dans des liposomes de manière à déstabiliser sélectivement les liposomes au voisinage de cellules cibles sécrétant de la peptidase et apporter ainsi les liposomes au voisinage de cellules cibles ou bien directement dans lesdites cellules. On peut par conséquent utiliser les liposomes pour traiter chez des mammifères des maladies, des dérèglements ou des états pahtologiques tels que des tumeurs, des infections microbiennes et des inflammations caractérisées par la présence de cellules sécrétant de la peptidase.
Ali Shaukat
Cabral-Lilly Donna
Erukulla Ravi K.
Franklin J. Craig
Janoff Andrew S.
Osler Hoskin & Harcourt Llp
The Liposome Company Inc.
Transave Inc.
LandOfFree
Peptide-lipid conjugates, liposomes and liposomal drug delivery does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Peptide-lipid conjugates, liposomes and liposomal drug delivery, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Peptide-lipid conjugates, liposomes and liposomal drug delivery will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1710452